2009
DOI: 10.1007/bf03086266
|View full text |Cite
|
Sign up to set email alerts
|

Giant cell arteritis as a cardiovascular entity

Abstract: Giant cell arteritis as a cardiovascular entityGiant cell arteritis (GCA) is a relatively infrequent disorder that is underdiagnosed and little appraised in the field of general cardiology. However, it is important to be familiar with the clinical picture of this disease, especially because of the risk of developing fatal aortic aneurysms. If the disease is suspected after a thorough history and clinical examination combined with laboratory investigation, the diagnosis can be confirmed with 18 F-2-deoxy-glucos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…As per guidelines, the initial evaluation of giant cell arteritis should include computed tomographic or magnetic resonance imaging of the thoracic aorta and branch vessels to assess aneurysm or occlusive disease [2]. Alternatively, the 18-fluorodeoxyglucose positron emission tomography (18-FDG PET) has been proposed as both a sensitive and specific diagnostic test that confirms an active vascular process when clinical symptoms and inflammatory markers are ambiguous or equivocal [27, 28]. In patients with confirmed or suspected temporal arteritis or polymyalgia rheumatica (PMA), PET was positive in 76% of patients with confirmed disease, in 23% with suspected disease, and in 2% of healthy controls, demonstrating the low rate of false positivity [29].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As per guidelines, the initial evaluation of giant cell arteritis should include computed tomographic or magnetic resonance imaging of the thoracic aorta and branch vessels to assess aneurysm or occlusive disease [2]. Alternatively, the 18-fluorodeoxyglucose positron emission tomography (18-FDG PET) has been proposed as both a sensitive and specific diagnostic test that confirms an active vascular process when clinical symptoms and inflammatory markers are ambiguous or equivocal [27, 28]. In patients with confirmed or suspected temporal arteritis or polymyalgia rheumatica (PMA), PET was positive in 76% of patients with confirmed disease, in 23% with suspected disease, and in 2% of healthy controls, demonstrating the low rate of false positivity [29].…”
Section: Discussionmentioning
confidence: 99%
“…In patients with confirmed or suspected temporal arteritis or polymyalgia rheumatica (PMA), PET was positive in 76% of patients with confirmed disease, in 23% with suspected disease, and in 2% of healthy controls, demonstrating the low rate of false positivity [29]. Suggested screening for aneurysms in patients with GCA includes baseline and annual abdominal ultrasound, chest radiography, and transthoracic echocardiography [28]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[3][4][5][6][7][8][9][10][11] The nine cases have been selected based on originality and potential educational interest to the reader. Topics of the case histories are the various manifestations of ischaemic heart disease varying from drug-induced myocardial infarction to aneurysms of coronary artery bypass grafts.…”
mentioning
confidence: 99%